Essers, B.A.B.

patient treatment study excision result health recurrence surgery attribute basal cell carcinoma analysis model carcinoma visibility –low visibility follow-up netherland level dutch visibility perception month outcome table cancer group tumours quality choice basal signi aesthetic assessment maastricht –effectivenes tumour transferability trastuzumab indicator choice experiment ficant mohs micrographic surgery di fference experiment difference university micrographic trial method health care signi ficant difference respondent evaluation breast fference number hospital state perspective maastricht university breast cancer effect 6 months probability esser information factor healthcare preference af flicted site 5 years quality indicators decision questionnaire regression margin willingness event adjuvant health-care dermatol